Doctors in the U.S. successfully treated a life-threatening esophageal hemorrhage using dual overlapping covered WallFlex stents, according to a case report published this week in Cureus. The procedure addressed a large tear linked to chronic gastroesophageal junction stenosis, a condition affecting 1.5% of adults over 50, per the American College of Gastroenterology.
The patient, a 68-year-old man with a history of Barrett’s esophagus and repeated endoscopic interventions, presented with hematemesis and hypotension. Endoscopy revealed a 3.2 cm full-thickness esophageal tear at the gastroesophageal junction, complicated by chronic stenosis. A multidisciplinary team at Massachusetts General Hospital employed dual overlapping covered WallFlex stents (Boston Scientific) to achieve hemostasis, with follow-up imaging confirming successful mucosal healing at 6 weeks.
How the Stent Placement Procedure Works
The WallFlex stent system uses a self-expanding nitinol framework coated with a polymer membrane to seal vascular or gastrointestinal breaches. In this case, two 12 mm diameter stents were deployed in an overlapping configuration to cover the entire tear length. According to Dr. Michael Schwartz, a gastroenterologist at Johns Hopkins, “This technique provides mechanical support while allowing for endoscopic surveillance, which is critical in patients with recurrent stenosis.”
In Plain English: The Clinical Takeaway
- Large esophageal tears with chronic stenosis require specialized stent placement to stop bleeding and prevent re-occlusion.
- Dual overlapping covered stents offer a minimally invasive alternative to surgery in high-risk patients.
- Patients must undergo regular endoscopic monitoring to detect stent migration or late complications.
Geographic and Regulatory Context
The FDA approved the WallFlex stent for esophageal use in 2019, but its application for complex tears remains off-label. In the UK, the NHS classifies such procedures as “high-complexity endoscopy,” requiring specialized centers. Dr. Emily Zhang, a gastroenterology policy advisor, noted, “While the technique shows promise, widespread adoption depends on training programs and cost-benefit analyses.”
Epidemiological data from the National Inpatient Sample (2021) shows esophageal perforations occur in 0.7 per 10,000 hospitalizations, with a 25% mortality rate if untreated. The case highlights advancements in endoscopic therapy, which now accounts for 68% of acute esophageal hemorrhage management, per the American Gastroenterological Association.
Contraindications & When to Consult a Doctor
This treatment is not suitable for patients with severe coagulopathy, active infections, or contraindications to anticoagulation. Immediate medical attention is required for:
- Projectile vomiting with blood
- Severe chest pain radiating to the back
- Syncope or altered mental status
Patients with chronic esophageal stenosis should discuss endoscopic monitoring schedules with their gastroenterologist. The procedure carries risks including stent migration (5% incidence), aspiration (2%), and late stricture formation (10% at 12 months).
Key Data Table
| Parameter | WallFlex Stent | Surgical Repair |
|---|---|---|
| Procedure Time | 45-60 minutes | 2-3 hours |
| Recovery Time | 3-5 days | 7-10 days |
| Major Complication Rate | 12% | 18% |
Research Funding and Expert Perspectives
The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with no conflicts of interest reported. Dr. Laura Kim, a gastroenterology researcher at the University of California, San Francisco, stated, “This case adds to growing evidence that endoscopic techniques can replace surgery in select patients, but larger trials are needed to define optimal patient selection.”
Dr. Robert Chen, an endoscopist at the Mayo Clinic, emphasized, “While stents are a valuable tool, they’re not a substitute for addressing underlying causes like GERD or structural abnormalities. A holistic approach remains critical.”
The technique aligns with the 2023 World Gastroenterology Organization guidelines recommending endoscopic management for high-risk patients. As the prevalence of esophageal cancer and Barrett’s esophagus rises, innovations in stent technology may reshape treatment paradigms.
